Ezetimibe and Simvastatin Reduce Inflammation, Disease Activity, and Aortic Stiffness and Improve Endothelial Function in Rheumatoid Arthritis

References

Page 1

	Year	Citations
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Anders Olsson, John J.V. McMurray, G Thorgeirsson, The Lancet Cardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemiaPreventive Cardiology	1994	8.5K
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial The Lancet Lipid DisorderCardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemia	2002	7K
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis M.L.L. Prevoo, Martin A. van't Hof, H. H. Kuper, Arthritis & Rheumatism	1995	6.1K
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen Atherosclerosis Supplements Cardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemiaPreventive Cardiology	2004	3.1K
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease Jacques Blacher, Alain P. Guérin, Bruno Pannier, Circulation	1999	2.1K
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction Jassim Al Suwaidi, Shuichi Hamasaki, Stuart T. Higano, Circulation	2000	2K
Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease J. Tuomilehto, Gabriele Vidgrén, L. Toivanen, The Lancet Metabolic SyndromeAutoimmune DiseaseInsulin-dependent Diabetes MellitusDiabetesImmunology	1994	1.7K
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure Eugene S. Chung, Milton Packer, Kim Hung Lo, Circulation	2003	1.6K
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events Paul M. Ridker, Nader Rifai, Michael Clearfield, New England Journal of Medicine	2001	1.6K
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein Paul M. Ridker, Nader Rifai, Marc A. Pfeffer, Circulation	1999	1.5K

Page 1